Liver
transplantation
is
a
life-saving
opportunity
for
patients
with
end-stage
liver
diseases
worldwide.There
are
two
types
of
transplants,
each
its
own
challenges.Even
brain
death
can
become
donors.Both
involve
preserving
and
reconstructing
vital
connections
this
essential
organ.Advances
in
field
offer
hope
those
advanced
diseases.An
analysis
transplants
Rio
de
Janeiro
over
14
years
aims
to
correlate
current
epidemiology
outcomes.Data
from
DATASUS
January
2008
December
2022
were
reviewed,
including
admissions,
public
expenditure,
complexity,
mortality,
deaths,
length
stay,
care,
as
well
articles
Scielo,
Lilacs,
PubMed.There
1,631
costing
R$146,798,794.70,
peak
terms
both
admissions
expenditure
(R$17,410,555.36).Of
these,
237
procedures
elective
1,394
urgent,
326
the
sector,
150
private
1,155
unknown
origin,
all
considered
high
complexity.The
overall
mortality
rate
was
11.89%,
194
deaths
recorded,
highest
being
2010
(25.93%)
lowest
2020
(6.25%).Mortality
higher
(12.24%)
sector
(19.94%)
compared
urgent
(11.84%)
(14.00%),
while
origin
had
9.35%.The
average
hospital
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(20), P. 11213 - 11213
Published: Oct. 18, 2024
Liver
inflammation
is
frequently
linked
to
oxidative
stress
and
dysregulation
of
bile
acid
fatty
metabolism.
This
review
focuses
on
the
farnesoid
X
receptor
(FXR),
a
critical
regulator
homeostasis,
its
interaction
with
nuclear
factor
erythroid
2-related
2
(Nrf2),
key
modulator
cellular
defense
against
stress.
The
explores
interplay
between
FXR
Nrf2
in
liver
inflammatory
diseases,
highlighting
potential
therapeutic
effects
natural
agonists.
Specifically,
compounds
such
as
auraptene,
cafestol,
curcumin,
fargesone
A,
hesperidin,
lycopene,
oleanolic
acid,
resveratrol,
rutin,
ursolic
withaferin
A
are
reviewed
for
their
ability
modulate
both
pathways.
article
discusses
alleviate
inflammation,
stress,
damage
diseases
metabolic-associated
disease
(MAFLD),
cholestatic
injury,
viral
hepatitis.
In
addition,
we
address
molecular
mechanisms
driving
including
immune
responses,
accumulation,
while
also
summarizing
relevant
experimental
models.
emphasizes
promising
targeting
pathways
using
compounds,
paving
way
future
treatments
diseases.
Finally,
limitations
clinical
application
were
indicated,
further
research
directions
proposed.
Phytotherapy Research,
Journal Year:
2024,
Volume and Issue:
38(8), P. 4202 - 4229
Published: June 26, 2024
Abstract
Glucolipid
metabolism
disorder
(GLMD)
is
a
complex
chronic
disease
characterized
by
glucose
and
lipid
disorders
with
diverse
etiology
rapidly
increasing
incidence.
Many
studies
have
identified
the
role
of
flavonoids
in
ameliorating
GLMD,
mechanisms
related
to
peroxisome
proliferator‐activated
receptors,
nuclear
factor
kappa‐B,
AMP‐activated
protein
kinase,
(erythroid‐derived
2)‐like
2,
transporter
type
4,
phosphatidylinositol‐3‐kinase/protein
kinase
B
pathway.
However,
comprehensive
summary
flavonoid
effects
on
GLMD
lacking.
This
study
reviewed
roles
natural
different
structures
treatment
reported
globally
past
5
years
provides
reference
for
developing
as
drugs
treating
GLMD.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(3), P. 413 - 413
Published: Jan. 23, 2025
Background:
Metabolic
syndrome
(MetS)
patients
have
impaired
hypothalamic
regulatory
functions
involved
in
food
intake
and
energy
expenditure
suffer
from
a
state
of
meta-inflammation.
Pre-clinical
studies
demonstrated
that
ultramicronized
palmitoylethanolamide
(PEA)
acts
both
on
the
adipose
tissue
central
nervous
system,
while
hydroxytyrosol
(HTyr)
counteracts
several
types
dysmetabolism.
Objectives:
The
aim
our
randomized
crossover
double-blind
placebo-controlled
pilot
study
was
to
evaluate
potential
effects
supplement
(FS)
containing
co-micronized
formulation
PEA
rutin
along
with
HTyr,
combined
tailored
calorie-controlled
Mediterranean
diet,
MetS.
Methods:
Nineteen
were
enrolled
block-randomized
an
eight-week
MD
together
FS
or
placebo.
After
two-week
washout
period,
treatments
reversed.
Data
laboratory
parameters
those
detected
by
capillary
sampling,
anthropometry,
body
composition
analysis,
ultrasound
examination,
blood
pressure
monitoring,
36-Item
Short-Form
Health
Survey
questionnaire,
handgrip
strength
test,
physical
performance
tests
collected
at
each
time
point
(protocol
code
R.S.
262.22,
registered
20
December
2022).
Results:
At
end
study,
supplemented
showed
significant
reduction
weight,
mass
index,
fat
mass,
inflammation
biomarkers
(CRP
ESR),
compared
placebo-supplemented
patients.
In
contrast,
fat-free
phase
angle,
cell
increased
placebo
Conclusions:
Although
preliminary,
results
clinical
suggest
PEA–rutin
HTyr
may
be
help
against
adiposopathy
Journal of Agricultural and Food Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 25, 2025
2-Amino-3-methylimidazole
[4,5-f]
quinoline
(IQ)
is
a
kind
of
heterocyclic
amine
(HCAs)
with
high
carcinogenicity
in
hot
processed
meat.
Rutin
(Ru)
flavonoid
compound
anti-inflammatory
and
antioxidant
properties.
However,
whether
Ru
scatheless
under
IQ-stimulated
potential
unhealthy
conditions,
especially
liver
function,
vivo,
unknown.
In
this
study,
we
explored
the
effects
underlying
mechanism
on
injury
induced
by
low
dose
IQ
mice.
Results
showed
that
supplement
led
to
upon
low-dose
alone
administration,
as
shown
histological
analysis,
inflammatory,
serum
biochemical
indexes.
Additionally,
nontargeted
metabolomics
analysis
revealed
coexposure
disrupted
metabolic
balance,
leading
significant
changes
metabolites
pathways,
hinting
at
possible
relationship
intestinal
microbiota.
Furthermore,
16S
rRNA
sequencing
data
indicated
combination
caused
gut
microbiota
dysbiosis
decreased
level
short-chain
fatty
acids
(SCFAs).
Correlation
between
microbiota,
SCFAs,
metabolites,
damage
markers
highlighted
crucial
role
gut-liver
axis
coexposure-induced
vivo.
general,
study
offers
valuable
perspective
flavones
HCA
compounds
realms
food
safety
human
health.
Frontiers in Nutrition,
Journal Year:
2025,
Volume and Issue:
12
Published: March 4, 2025
Globally,
metabolic
dysfunction-associated
fatty
liver
disease
(MAFLD),
also
known
as
non-alcoholic
(NAFLD)
or
steatotic
(MASLD),
is
a
common
chronic
disease.
The
progression
of
MAFLD
leads
to
vicious
cycle
in
which
oxidative
stress
results
from
the
that
augmenting
de-novo
lipid
levels
and
increases
steatosis.
Most
non-enzymatic
antioxidants
are
present
food.
Therefore,
review
summarizes
findings
studies
on
food-derived
presents
an
stress-related
regulatory
network
MAFLD,
offering
new
ideas
for
prevention
treatment.